Site 41 - 1st Immunology & Clinical Research 3260 East 104th Avenue — Thornton, Colorado

Site 41 - 1st Immunology & Clinical Research 3260 East 104th Avenue is a clinical research site located in Thornton, Colorado, United States 80233.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Site 41 - 1st Immunology & Clinical Research 3260 East 104th Avenue has participated in 1 clinical trials.

Therapeutic areas: Meningococcal Infections.

Sponsors: Novartis Vaccines.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Site 41 - 1st Immunology & Clinical Research 3260 East 104th Avenue?

Site 41 - 1st Immunology & Clinical Research 3260 East 104th Avenue has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Site 41 - 1st Immunology & Clinical Research 3260 East 104th Avenue conducted?

Site 41 - 1st Immunology & Clinical Research 3260 East 104th Avenue has 1 clinical trials on record. Their work covers Meningococcal Infections.

Is Site 41 - 1st Immunology & Clinical Research 3260 East 104th Avenue accredited by Crixeo Health?

Site 41 - 1st Immunology & Clinical Research 3260 East 104th Avenue has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Site 41 - 1st Immunology & Clinical Research 3260 East 104th Avenue?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.